Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More General business news KKR to buy 60% stake in environmental services provider Ramky Enviro Global investment firm KKR has agreed to acquire a stake of 60% in Indian environmental services provider Ramky… bySoujanya RaviAugust 18, 2018
